首页> 外国专利> Oral dosage form comprising a Core containing an active principle of erodible Basic character weak,An erodible Coating surrounding Said Core with one or more Opening atraviesn Coating and connect to the core with the Environment of use; Preparation procedure; and use (Divisional260 - 03).

Oral dosage form comprising a Core containing an active principle of erodible Basic character weak,An erodible Coating surrounding Said Core with one or more Opening atraviesn Coating and connect to the core with the Environment of use; Preparation procedure; and use (Divisional260 - 03).

机译：口服剂型，其包含具有易蚀基本特征弱的活性成分的核，围绕所述核的易蚀涂层，其具有一个或多个开口涂层，并与使用环境连接至核;准备程序;并使用（Divisional260-03）。

页面导航

摘要
著录项
相似文献

摘要

Oral dosage form comprising an erodible Core comprising a pharmaceutically Active and weak base erodible Coating around the Core; and preparac procedureIon (Div. Sun. 260 - 03).

机译：口服剂型，其包含易蚀的核心，所述易蚀的核心包括在所述核心周围的药学活性和弱碱易蚀的涂层。和预处理程序（Div。Sun. 260-03）。

著录项

公开/公告号CL2007003010A1

专利类型
公开/公告日2008-01-25

原文格式PDF
申请/专利权人 GLAXO GROUP LIMITED;
展开▼

申请/专利号CL20070003010
发明设计人 MARTINI LUIGI;RE VINCENZO;LI CHI LEUNG;WILLY HELEN ANNE.;
展开▼

申请日2007-10-19
分类号A61K9/44;A61P3/00;
国家 CL
入库时间 2022-08-21 20:08:32

相似文献

专利
外文文献